Altered microRNA expression profile in amyotrophic lateral sclerosis: A role in the regulation of NFL mRNA levels

Molecular Brain

Volumn 6, Issue 1, 2013, Pages

  Campos Melo, Danae ^a   Droppelmann, Cristian A ^a   He, Zhongping ^a   Volkening, Kathryn ^a,c   Strong, Michael J ^a,b,c,d  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c WESTERN UNIVERSITY   (Canada)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Amyotrophic lateral sclerosis; miRNA; Neurofilament

Indexed keywords

MICRORNA; NEUROFILAMENT PROTEIN; 3' UNTRANSLATED REGION; LUCIFERASE; MESSENGER RNA; NEUROFILAMENT PROTEIN L;

3' UNTRANSLATED REGION; ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CAUSE OF DEATH; CELL STRAIN HEK293; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MALE; NERVOUS SYSTEM FUNCTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; AGED; CASE CONTROL STUDY; CELL DEATH; DEMOGRAPHY; GENE REGULATORY NETWORK; GENETICS; HEK293 CELL LINE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; NERVOUS SYSTEM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; REPORTER GENE; SEQUENCE ALIGNMENT; SPINAL CORD; UPREGULATION;

3' UNTRANSLATED REGIONS; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; BASE SEQUENCE; CASE-CONTROL STUDIES; CELL DEATH; DEMOGRAPHY; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENES, REPORTER; HEK293 CELLS; HUMANS; LUCIFERASES; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NERVOUS SYSTEM; NEUROFILAMENT PROTEINS; RNA, MESSENGER; SEQUENCE ALIGNMENT; SPINAL CORD; UP-REGULATION;

EID: 84878005741     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-6-26     Document Type: Article

References (51)

1. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Rosen DR, Nature 1993 364 362 8332197
2. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, Patterson V, Swingler R, Kieran D, Prehn J, Nat Genet 2006 38 411 413 10.1038/ng1742 16501576
3. Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Wu D, Yu W, Kishikawa H, Folkerth RD, Iafrate AJ, Shen Y, Xin W, Sims K, Hu GF, Ann Neurol 2007 62 609 617 10.1002/ana.21221 17886298
4. Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Pesiridis GS, Lee VM, Trojanowski JQ, Hum Mol Genet 2009 18 156 R162 10.1093/hmg/ddp303 19808791
5. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, Bouchard JP, Lacomblez L, Pochigaeva K, Salachas F, Nat Genet 2008 40 572 574 10.1038/ng.132 18372902
6. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E, Science 2008 319 1668 1672 10.1126/science.1154584 18309045
7. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, Science 2009 323 1208 1211 10.1126/science.1165942 19251628
8. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, Science 2009 323 1205 1208 10.1126/science.1166066 19251627
9. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Neuron 2011 72 245 256 10.1016/j.neuron.2011.09.011 21944778
10. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Neuron 2011 72 257 268 10.1016/j.neuron.2011.09.010 21944779
11. The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS). Strong MJ, J Neurol Sci 2010 288 1 12 10.1016/j.jns.2009.09.029 19840884
12. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS). Volkening K, Leystra-Lantz C, Yang W, Jaffee H, Strong MJ, Brain Res 2009 1305 168 182 19815002
13. Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. Bergeron C, Beric-Maskarel K, Muntasser S, Weyer L, Somerville MJ, Percy ME, J Neuropathol Exp Neurol 1994 53 221 230 10.1097/00005072-199405000-00002 7909836
14. Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis. Menzies FM, Grierson AJ, Cookson MR, Heath PR, Tomkins J, Figlewicz DA, Ince PG, Shaw PJ, J Neurochem 2002 82 1118 1128 12358759
15. Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). Wong NK, He BP, Strong MJ, J Neuropathol Exp Neurol 2000 59 972 982 11089575
16. Mutant copper-zinc superoxide dismutase binds to and destabilizes human low molecular weight neurofilament mRNA. Ge WW, Wen W, Strong W, Leystra-Lantz C, Strong MJ, J Biol Chem 2005 280 118 124 15507437
17. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Strong MJ, Volkening K, Hammond R, Yang W, Strong W, Leystra-Lantz C, Shoesmith C, Mol Cell Neurosci 2007 35 320 327 10.1016/j.mcn.2007.03.007 17481916
18. Rho Guanine nucleotide exchange factor is a NFL mRNA destabilizing factor that forms cytoplasmic inclusions in amyotrophic lateral sclerosis. Droppelmann CA, Keller BA, Campos-Melo D, Volkening K, Strong MJ, Neurobiol Aging 2013 34 248 262 10.1016/j.neurobiolaging.2012.06.021 22835604
19. Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: implications for TDP-43 in the physiological response to neuronal injury. Moisse K, Volkening K, Leystra-Lantz C, Welch I, Hill T, Strong MJ, Brain Res 2009 1249 202 211 19046946
20. TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. Wang IF, Wu LS, Chang HY, Shen CK, J Neurochem 2008 105 797 806 10.1111/j.1471-4159.2007.05190.x 18088371
21. Anderson P, Kedersha N, RNA granules. J Cell Biol 2006 172 803 808 10.1083/jcb.200512082
22. Stress granules: the Tao of RNA triage. Anderson P, Kedersha N, Trends Biochem Sci 2008 33 141 150 10.1016/j.tibs.2007.12.003 18291657
23. microPrimer: the biogenesis and function of microRNA. Du T, Zamore PD, Development 2005 132 4645 4652 10.1242/dev.02070 16224044
24. MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Kapsimali M, Kloosterman WP, de Bruijn E, Rosa F, Plasterk RH, Wilson SW, Genome Biol 2007 8 173 10.1186/gb-2007-8-8-r173 17711588
25. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Cheng LC, Pastrana E, Tavazoie M, Doetsch F, Nat Neurosci 2009 12 399 408 10.1038/nn.2294 19287386
26. Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation. Liu C, Teng ZQ, Santistevan NJ, Szulwach KE, Guo W, Jin P, Zhao X, Cell Stem Cell 2010 6 433 444 10.1016/j.stem.2010.02.017 20452318
27. Experience-dependent expression of miR-132 regulates ocular dominance plasticity. Tognini P, Putignano E, Coatti A, Pizzorusso T, Nat Neurosci 2011 14 1237 1239 10.1038/nn.2920 21892154
28. A MicroRNA feedback circuit in midbrain dopamine neurons. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A, Science 2007 317 1220 1224 10.1126/science.1140481 17761882
29. Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Wang WX, Huang Q, Hu Y, Stromberg AJ, Nelson PT, Acta Neuropathol 2011 121 193 205 10.1007/s00401-010- 0756-0 20936480
30. Altered microRNA regulation in Huntington's disease models. Lee ST, Chu K, Im WS, Yoon HJ, Im JY, Park JE, Park KH, Jung KH, Lee SK, Kim M, Roh JK, Exp Neurol 2011 227 172 179 10.1016/j.expneurol.2010.10.012 21035445
31. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. Boissonneault V, Plante I, Rivest S, Provost P, J Biol Chem 2009 284 1971 1981 18986979
32. MicroRNAs (miRNAs) in neurodegenerative diseases. Nelson PT, Wang WX, Rajeev BW, Brain Pathol 2008 18 130 138 10.1111/j.1750-3639.2007.00120.x 18226108
33. RNA in brain disease: no longer just "the messenger in the middle" Nelson PT, Keller JN, J Neuropathol Exp Neurol 2007 66 461 468 10.1097/01.jnen.0000240474.27791.f3 17549006
34. A miRNA signature of prion induced neurodegeneration. Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA, PLoS One 2008 3 3652 10.1371/journal. pone.0003652 18987751
35. miRNA malfunction causes spinal motor neuron disease. Haramati S, Chapnik E, Sztainberg Y, Eilam R, Zwang R, Gershoni N, McGlinn E, Heiser PW, Wills AM, Wirguin I, Proc Natl Acad Sci U S A 2010 107 13111 13116 10.1073/pnas.1006151107 20616011
36. Principles of microRNA-target recognition. Brennecke J, Stark A, Russell RB, Cohen SM, PLoS Biol 2005 3 85 10.1371/journal.pbio.0030085 15723116
37. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I, Nelson PT, J Neurosci 2008 28 1213 1223 10.1523/JNEUROSCI.5065-07.2008 18234899
38. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Minones-Moyano E, Porta S, Escaramis G, Rabionet R, Iraola S, Kagerbauer B, Espinosa-Parrilla Y, Ferrer I, Estivill X, Marti E, Hum Mol Genet 2011 20 3067 3078 10.1093/hmg/ddr210 21558425
39. A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing. Marti E, Pantano L, Banez-Coronel M, Llorens F, Minones-Moyano E, Porta S, Sumoy L, Ferrer I, Estivill X, Nucleic Acids Res 2010 38 7219 7235 10.1093/nar/gkq575 20591823
40. Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations. Kocerha J, Kouri N, Baker M, Finch N, DeJesus-Hernandez M, Gonzalez J, Chidamparam K, Josephs KA, Boeve BF, Graff-Radford NR, BMC Genomics 2011 12 527 10.1186/1471-2164-12-527 22032330
41. Selective loss of trans-acting instability determinants of neurofilament mRNA in amyotrophic lateral sclerosis spinal cord. Ge WW, Leystra-Lantz C, Wen W, Strong MJ, J Biol Chem 2003 278 26558 26563 10.1074/jbc.M302886200 12730211
42. Intermediate filament steady-state mRNA levels in amyotrophic lateral sclerosis. Strong MJ, Leystra-Lantz C, Ge WW, Biochem Biophys Res Commun 2004 316 317 322 10.1016/j.bbrc.2004.02.051 15020220
43. MicroRNA-mediated up-regulation of an alternatively polyadenylated variant of the mouse cytoplasmic {beta}-actin gene. Ghosh T, Soni K, Scaria V, Halimani M, Bhattacharjee C, Pillai B, Nucleic Acids Res 2008 36 6318 6332 10.1093/nar/gkn624 18835850
44. MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation. Ma F, Liu X, Li D, Wang P, Li N, Lu L, Cao X, J Immunol 2010 184 6053 6059 10.4049/jimmunol.0902308 20410487
45. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP, Mol Cell 2007 27 91 105 10.1016/j.molcel.2007.06.017 17612493
46. The impact of microRNAs on protein output. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP, Nature 2008 455 64 71 10.1038/nature07242 18668037
47. Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region. Wu S, Huang S, Ding J, Zhao Y, Liang L, Liu T, Zhan R, He X, Oncogene 2010 29 2302 2308 10.1038/onc.2010.34 20190813
48. MicroRNA profile indicates downregulation of the TGFbeta pathway in sporadic non-functioning pituitary adenomas. Butz H, Liko I, Czirjak S, Igaz P, Korbonits M, Racz K, Patocs A, Pituitary 2011 14 112 124 10.1007/s11102-010- 0268-x 21063788
49. Human MicroRNA targets. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS, PLoS Biol 2004 2 363 10.1371/journal.pbio.0020363 15502875
50. Mfold web server for nucleic acid folding and hybridization prediction. Zuker M, Nucleic Acids Res 2003 31 3406 3415 10.1093/nar/gkg595 12824337
51. Fast and effective prediction of microRNA/target duplexes. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R, RNA 2004 10 1507 1517 10.1261/rna.5248604 15383676